News 27 mai 2024 Securecell and DataHow collaborating with British partner for cell research Securecell and DataHow are working together as part of a British-Swiss project to promote innovation in relation to the development of cell and g...
News 24 mai 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
News 17 abr 2024 Symbio invests CHF 12 million in new research facility in Corminboeuf Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.
News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 12 abr 2024 Carrier plans new regional innovation & technology center in Lucerne, Switzerland Carrier Global Corporation is planning a new innovation and technology centre in Lucerne. This strategic investment consolidates its position as ...
News 24 jan 2024 Odne secures fifth investment from the Dental Innovation Alliance The North American venture capital firm Dental Innovation Alliance has made a fifth investment in Odne. This will support the market launch of an...
News 27 out 2023 Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence (AI). The goal is to help patholo...
News 21 nov 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Aktuell 21 nov 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
News 04 out 2023 US health agency links up with the Paul Scherrer Institute Researchers from the Paul Scherrer Institute are working on an efficient method of mapping the brain of a mouse. As part of the BRAIN Initiative,...
News 26 abr 2023 Siegfried breaks ground on new global R&D Center for Drug Substances in Evionnaz Siegfried will create a new global R&D Center in Evionnaz, investing CHF 25 million to boost capacity, drive growth, and leading to the creation ...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
Press Release 15 dez 2022 Swiss technology for digital worlds For the fifth time in a row, Switzerland is taking part in the Consumer Electronics Show (CES) in Las Vegas. Under the motto "swisstech for exten...
News 13 set 2023 HAYA Therapeutics triumphs at the 13th TOP 100 Swiss Startup Award Western Switzerland’s burgeoning start-up scene witnessed another remarkable year of innovation and growth as Haya Therapeutics won the first pla...
News 02 nov 2023 Four innovative Geneva start-ups receive FIF support Geneva's FIF has backed four promising start-ups, fostering innovation in line with the UN's Sustainable Development Goals.
News 03 nov 2023 A new gel offers targeted relief for ulcerative colitis patients Researchers at the University of Bern have developed a lipid gel for direct, localized treatment of ulcerative colitis, aiming to reduce side eff...
News 29 set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...